Prontosan for acute and chronic wounds. It is indicated for cleansing, decontaminating and moistening acute and chronic wounds and to prevent and remove biofilms. Due to an error, recently brought to our attention, during the processing of the consultation responses, a stakeholder submission was missed and was therefore was not included in the documentation presented to committee. In order to ensure a full and transparent process, we will now re-run the consultation process for Prontosan, and return to a second committee meeting at which all comments from the first and second consultation will be presented to committee. The dates on the website have been updated to reflect this. We appreciate this delay in guidance production maybe disappointing, however this will rectify the issue and ensure the guidance is robust and transparently developed.
Status In progress
Process MT
ID number 551

Provisional Schedule

Committee meeting: 2 10 December 2021
Resolution 24 January 2022
Expected publication 08 March 2022

Project Team

Project lead Lirije Hyseni

Email enquiries


External assessment group CEDAR
Manufacturers B. Braun Medical Ltd
Others Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  Boston Scientific
  Department of Health and Social Care
  Devices for Dignity
  Greater Manchester Health & Social Care Partnership
  Healthcare Improvement Scotland
  HealthTech Alliance
  Johnson & Johnson Medical Ltd
  Medical Technology Group
  Medicines and Healthcare Products Regulatory Agency
  University of Manchester Wounds Research Group
  NHS England
  The British In Vitro Diagnostics Association (BIVDA)
  NHS Digital
  Association of Surgeons of Great Britain and Ireland
  British Obesity and Metabolic Surgery Society
  British Obesity Surgery Society
  British Pain Society
  Community Practitioners' & Health Visitors Association
  Primary Care Diabetes Society
  Royal College of General Practitioners
  Royal College of Nursing
  Royal college of Surgeons
  Society of Vascular Nurses
  Surgical Dressing Manufacturers Association
  The Vascular Society
  Tissue Viability Society
  Association for Perioperative Practice
  British Association of Pediatric Surgeons
  British Association of Plastic Reconstructive and Aesthetic Surgeons
  Royal College of Obstetricians and Gynecologists'


Key events during the development of the guidance:

Date Update
11 October 2021 - 08 November 2021 Draft guidance
23 April 2021 Committee meeting: 1
27 November 2020 Scope published
21 October 2020 Stakeholder registration opens

For further information on how we develop guidance, please see our page about NICE medical technologies guidance